Orthopedic Biomaterials Market worth $24.86 billion by 2030

 The report “Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) — Forecast to 2030” is projected to grow from USD 16.95 billion in 2025 and to reach USD 24.86 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period.

Browse 908 market data Tables and 50 Figures spread through 663 Pages and in-depth TOC on “Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) — Forecast to 2030”
View detailed Table of Content here — https://www.marketsandmarkets.com/Market-Reports/orthopedic-biomaterials-market-221903530.html

The orthopedic biomaterials market is experiencing growth, driven by several key factors, including the broad adoption across medical devices, drug delivery systems, and tissue repair applications, as well as cost advantages compared to metallic and ceramic biomaterials in high-volume applications.

The stainless steel segment accounted for the largest share of the metallic biomaterials market, by type, in 2024.

By metallic biomaterials type, the market is segmented into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, magnesium, and other metallic biomaterials. The stainless steel segment accounted for the largest share of the orthopedic biomaterials market in 2024, due to its application in trauma fixation products such as plates, screws, rods, and pins, where strength, reliability, and economy are key considerations. Stainless steel is renowned for its strength, corrosion resistance, and ease of manufacture, making it a suitable material for high-volume orthopedic applications. Also, it has a history of successful usage and widespread acceptance among orthopedic manufacturers and hospitals.

The knee replacement segment is projected to register the fastest growth during the forecast period.

By joint replacement application, the market is segmented into knee replacement, hip replacement, shoulder replacement, and other joint replacement procedures. Knee replacement has emerged as the fastest-growing market for orthopedic biomaterials. The reason for this growth is a substantial increase in knee arthroplasty procedures, driven by an aging population, rising obesity cases, and older individuals seeking an active lifestyle. The adoption of PMMA bone cement, UHMWPE, and PEEK bearing surfaces, as well as metallic implants, in knee procedures is another factor contributing to market growth. Moreover, an increase in life expectancy and technological advancements in knee implants are leading to a rise in revision procedures

North America accounted for the largest regional share of the orthopedic biomaterials market in 2024.

The market for orthopedic biomaterials is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the largest share of the orthopedic biomaterials market in 2024. This can be attributed to the high volumes of joint replacements and spine procedures, strong reimbursement, and the rapid adoption of premium implant technologies. Additional growth drivers include the presence of leading orthopedic OEMs and raw material suppliers, intensive R&D and clinical trial activity in bioresorbable and smart biomaterials, and a well-developed hospital infrastructure that supports complex arthroplasty and trauma care.

Key players in the orthopedic biomaterials market include Celanese Corporation (US), Carpenter Technology Corporation (US), Evonik Industries AG (Germany), DSM (Netherlands), Corbion NV (Netherlands), CoorsTek Inc (US), Berkeley Advanced Materials (US), and CAM Bioceramics B.V. (Netherlands)

RECENT DEVELOPMENTS

  • April 2025 : Carpenter Technology Corporation advanced its orthopedic materials offering by strengthening production of high-purity stainless steel and titanium alloys for trauma fixation and joint replacement devices, addressing growing demand for durable and fatigue-resistant implant materials.
  • March 2025 : Celanese Corporation expanded its medical-grade UHMWPE portfolio for orthopedic implants, supporting improved wear resistance and longer implant life in hip and knee replacement applications, reinforcing its position as a key materials supplier to global orthopedic OEMs.

Comments

Post a Comment

Popular posts from this blog

Adhesion Barrier Industry worth $0.9 billion by 2028, with a CAGR of 7.4%

  The report   " Adhesion Barrier Market  by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region- Global Forecast to 2028" , is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 billion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers of this market's expansion are the rising number of surgeries and sports-related injuries, an increasing elderly population, and a growing understanding by of the adhesion formation and health issues linked to adhesions. On the other hand, during the forecast period, it is projected that surgeons' resistance to using adhesion barriers will impede market expansion. Browse 207 market data Tables and 50 Figures spread through 238 Pages and in-depth TOC on  "Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (F...
Read more

Exploring the Versatile Uses of Liquid Biopsies in Modern Medicine

Image
 In recent years, liquid biopsy has emerged as a groundbreaking tool in the field of medicine, offering a less invasive alternative to traditional tissue biopsies. This innovative technique, which involves the analysis of biomarkers in bodily fluids such as blood, urine, or saliva, is revolutionizing the way we diagnose, monitor, and treat various diseases. Let’s delve into the versatile uses of liquid biopsies and how they are transforming healthcare. Download PDF Brochure 1. Cancer Detection and Diagnosis One of the most significant uses of liquid biopsy is in the early detection and diagnosis of cancer. Traditional tissue biopsies can be invasive, painful, and sometimes risky. In contrast, liquid biopsies offer a non-invasive way to detect cancerous cells or DNA fragments (circulating tumor DNA or ctDNA) in the bloodstream. This allows for the identification of cancer at an earlier stage, often before symptoms appear, which can lead to more effective treatment options and i...
Read more

Exploring the Impact of Animal Genetics Testing: Revolutionizing Animal Breeding and Health

Image
 In recent years, animal genetics testing has emerged as a game-changer in the field of veterinary science and animal breeding. By unlocking the genetic makeup of animals, this innovative technology allows for a deeper understanding of their traits, health, and lineage. The implications of these insights are profound, offering significant benefits for breeders, farmers, veterinarians, and pet owners alike. Download PDF Brochure Understanding Animal Genetics Testing Animal genetics testing involves analyzing an animal's DNA to identify specific genetic markers associated with various traits and conditions. These tests can be used to determine parentage, predict the likelihood of certain diseases, and even select for desirable traits in breeding programs. The technology behind these tests has advanced rapidly, making them more accessible and affordable than ever before. Applications in Breeding One of the most significant applications of animal genetics testing is in selecti...
Read more